Skip to main content
Clinical Trials/NCT07399379
NCT07399379
Completed
Not Applicable

Implementation of an Augmented Reality System to Complement Discharge Information in Hospitalized Cardiology Patients

Hospital Universitario Getafe1 site in 1 country303 target enrollmentStarted: February 23, 2024Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Hospital Universitario Getafe
Enrollment
303
Locations
1
Primary Endpoint
PRIMARY OUTCOME: PREM and treatment adherence at one and six months

Overview

Brief Summary

The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information.

This study includes adult patients who are admitted to a cardiology department because of:

  • Ischaemic heart disease
  • Atrial fibrillation
  • Heart failure
  • Or who need a pacemaker implantation

The main questions this study aims to answer are:

  • Does providing augmented reality information at discharge improve patients' perceived quality of care?
  • Does it improve patients' adherence to their prescribed treatment?
  • Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death?

Researchers will compare two groups of participants:

  • A control group, who will receive the usual medical discharge report.
  • An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application.

Participants will:

  • Receive their discharge information according to the group they are assigned to.
  • Use the augmented reality application if they are in the intervention group.
  • Be followed over time to assess treatment adherence, patient experience, and cardiovascular events.

This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participants must have access to a mobile device (such as a smartphone or tablet).
  • Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.

Exclusion Criteria

  • No access to a mobile device.
  • Untreated visual or hearing impairments that prevent viewing or understanding the videos.
  • Inability to understand Spanish

Arms & Interventions

Intervention Group

Active Comparator

This group receives the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application explaining their disease.

Intervention: Augmented reality app (Device)

Control group

No Intervention

This group receives the usual medical discharge report.

Outcomes

Primary Outcomes

PRIMARY OUTCOME: PREM and treatment adherence at one and six months

Time Frame: Follow up at one and six months from enrollment

To assess PREM (Patient-Reported Experience Measures) in the intervention group and in the control group at discharge and at follow-up.

Secondary Outcomes

  • MACE at one and six months(From enrollment at one and six months)

Investigators

Sponsor
Hospital Universitario Getafe
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials